| Date Filed | Type | Description |
| 07/03/2023 |
4
| MARAGANORE JOHN (Director) has filed a Form 4 on PROKIDNEY CORP.|
Txns:
| Granted 48,128 options to buy
@ $10.56, valued at
$508.2k
|
|
| 06/08/2023 |
4
| MARAGANORE JOHN (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 16,532 options to buy
@ $34.33, valued at
$567.5k
|
|
| 02/03/2023 |
5
| MARAGANORE JOHN (Director) has filed a Form 5 on AGIOS PHARMACEUTICALS, INC. |
| 09/02/2022 |
4
| MARAGANORE JOHN (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 10,391 options to buy
@ $55.58, valued at
$577.5k
|
|
| 07/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/23/2022 |
4
| MARAGANORE JOHN (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Granted 4,975 restricted stock units
@ $0
Granted 29,307 options to buy
@ $18.09, valued at
$530.2k
|
|
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/19/2022 |
4
| MARAGANORE JOHN (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Granted 24,000 options to buy
@ $39.61, valued at
$950.6k
|
|
| 01/19/2022 |
3
| MARAGANORE JOHN (Director) has filed a Form 3 on Kymera Therapeutics, Inc. |
| 12/23/2021 |
4
| MARAGANORE JOHN (CEO) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 14,167 shares
@ $0
Paid exercise price by delivering 6,315 shares
@ $189.13, valued at
$1.2M
Paid exercise price by delivering 2 shares
@ $190.5, valued at
$381
Paid exercise price by delivering 319 shares
@ $186.02, valued at
$59.3k
|
|
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2021 |
4
| MARAGANORE JOHN (CEO) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 10,365 shares
@ $170.36, valued at
$1.8M
Sold 7,742 shares
@ $171.35, valued at
$1.3M
Sold 14,518 shares
@ $172.22, valued at
$2.5M
Sold 683 shares
@ $173.25, valued at
$118.3k
Sold 670 shares
@ $174.34, valued at
$116.8k
Exercised 33,978 options to buy
@ $7.1, valued at
$241.2k
|
|
| 11/08/2021 |
4
| MARAGANORE JOHN (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 13,133 options to buy
@ $89.53, valued at
$1.2M
|
|
| 11/08/2021 |
3
| MARAGANORE JOHN (Director) has filed a Form 3 on Beam Therapeutics Inc. |
| 08/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/20/2020 |
4
| MARAGANORE JOHN (CEO) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 18,987 shares
@ $123.55, valued at
$2.3M
Sold 5,489 shares
@ $124.49, valued at
$683.3k
Sold 10,187 shares
@ $125.35, valued at
$1.3M
Sold 102 shares
@ $126.62, valued at
$12.9k
Exercised 34,765 options to buy
@ $9.14, valued at
$317.8k
|
|
| 08/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2020 |
4
| MARAGANORE JOHN (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Granted 8,096 options to buy
@ $53.35, valued at
$431.9k
Granted 1,686 restricted stock units
@ $0
Exercised 1,878 restricted stock units
@ $0 |
|
| 05/22/2020 |
4
| MARAGANORE JOHN (CEO) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 13,437 shares
@ $142.51, valued at
$1.9M
Sold 16,315 shares
@ $143.46, valued at
$2.3M
Sold 5,013 shares
@ $144.33, valued at
$723.5k
Exercised 34,765 options to buy
@ $9.14, valued at
$317.8k
|
|
| 04/09/2020 |
4
| MARAGANORE JOHN (CEO) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 14,167 shares
@ $0
Paid exercise price by delivering 6,315 shares
@ $104.75, valued at
$661.5k
Paid exercise price by delivering 256 shares
@ $106.27, valued at
$27.2k
|
|
| 02/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/21/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/26/2019 |
4
| MARAGANORE JOHN (CEO) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Granted 17,498 options to buy
@ $119.13, valued at
$2.1M
|
|
| 10/16/2019 |
4
| MARAGANORE JOHN (CEO) has filed a Form 4 on ALNYLAM PHARMACEUTICALS, INC.|
Txns:
| Sold 20,832 shares
@ $78.92, valued at
$1.6M
Sold 26,754 shares
@ $79.8, valued at
$2.1M
Sold 1,870 shares
@ $80.31, valued at
$150.2k
Exercised 49,456 options to buy
@ $16.43, valued at
$812.6k
|
|
| 08/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|